Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on June 1, 2025

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

3 days ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

6 days ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Crispr Therapeutics call volume above normal and directionally bullish

TipRanks

11 days ago

Crispr Therapeutics call volume above normal and directionally bullish

3 Top Genomics Stocks to Add to Your Portfolio in 2025

Zacks

11 days ago

3 Top Genomics Stocks to Add to Your Portfolio in 2025

MT Newswires

11 days ago

Mizuho Cuts Price Target on CRISPR Therapeutics to $85 From $99, Keeps Outperform Rating

CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug

Insider Monkey

12 days ago

CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies

Zacks

12 days ago

CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies

5 Monster Stocks to Hold for the Next 10 Years

Motley Fool

13 days ago

5 Monster Stocks to Hold for the Next 10 Years

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool

13 days ago

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

MT Newswires

13 days ago

CRISPR, Sirius Collaborate on RNA Therapy Targeting Blood Clot Disorders

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

GlobeNewswire

13 days ago

CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Motley Fool

14 days ago

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Motley Fool

18 days ago

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

19 days ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Biotech Stocks That Are Screaming Buys in May

Motley Fool

19 days ago

2 Biotech Stocks That Are Screaming Buys in May

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Motley Fool

20 days ago

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

3 Monster Stocks to Hold for the Next 10 Years

Motley Fool

22 days ago

3 Monster Stocks to Hold for the Next 10 Years

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Simply Wall St.

24 days ago

CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

24 days ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

Zacks

24 days ago

Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

24 days ago

CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

Zacks

25 days ago

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

Simply Wall St.

25 days ago

We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

GlobeNewswire

a month ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

Zacks

a month ago

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

2 Beaten-Down Stocks With Incredible Upside Potential

Motley Fool

a month ago

2 Beaten-Down Stocks With Incredible Upside Potential

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

a month ago

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Morningstar Research

a month ago

Analyst Report: CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

TipRanks

a month ago

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

MT Newswires

a month ago

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

Simply Wall St.

2 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

2 months ago

3 Magnificent Stocks That Could Double or More by 2030

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

2 months ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Motley Fool

2 months ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

2 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

Simply Wall St.

2 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Motley Fool

2 months ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

2 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

2 months ago

RBC Cuts Price Target on CRISPR Therapeutics to $38 From $48, Keeps Sector Perform, Speculative Risk

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

2 months ago

Biotech stocks slide as Marks resignation seen being negative for sector

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Investor's Business Daily

2 months ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool

2 months ago

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

2 months ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

Investor's Business Daily

2 months ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Zacks

2 months ago

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks

2 months ago

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Novo gains Lexicon obesity drug; CRISPR COO to step down

BioPharma Dive

2 months ago

Novo gains Lexicon obesity drug; CRISPR COO to step down

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

Simply Wall St.

2 months ago

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

MT Newswires

2 months ago

CRISPR Therapeutics COO to Step Down

CRISPR Therapeutics Announces Transition of Chief Operating Officer

GlobeNewswire

2 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

2 months ago

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

2 months ago

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

2 months ago

2 Beaten-Down Stocks to Buy on the Dip

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

2 months ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

2 No-Brainer Biotech Stocks to Buy Right Now

Motley Fool

2 months ago

2 No-Brainer Biotech Stocks to Buy Right Now

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

Insider Monkey

2 months ago

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks

2 months ago

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

Insider Monkey

2 months ago

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

Zacks

3 months ago

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Pharmaceutical Technology

3 months ago

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

Simply Wall St.

3 months ago

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 03/03/2025

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool

3 months ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

Motley Fool

3 months ago

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks

3 months ago

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Investing.com

4 months ago

Street Calls of the Week

Why CRISPR Therapeutics (CRSP) Soared on Friday?

Insider Monkey

4 months ago

Why CRISPR Therapeutics (CRSP) Soared on Friday?

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

4 months ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

GuruFocus.com

4 months ago

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Motley Fool

4 months ago

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Morningstar Research

4 months ago

Analyst Report: CRISPR Therapeutics AG

Crispr Therapeutics price target raised to $86 from $85 at BofA

TipRanks

4 months ago

Crispr Therapeutics price target raised to $86 from $85 at BofA

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

4 months ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

4 months ago

Truist Securities Adjusts Price Target on CRISPR Therapeutics to $120 From $100, Keeps Buy Rating

MT Newswires

4 months ago

TD Cowen Upgrades CRISPR Therapeutics to Hold From Sell, Adjusts Price Target to $35 From $30

MT Newswires

4 months ago

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires

4 months ago

CRISPR Therapeutics Swings to Q4 Loss, Revenue Falls

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

4 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

4 months ago

BofA Securities Adjusts CRISPR Therapeutics Price Target to $86 From $85, Maintains Buy Rating

Share on Social Networks: